Literature DB >> 14745382

Policy decision options during the first 5 years following certification of polio eradication.

Nalinee Sangrujee1, Radboud J Duintjer Tebbens, Victor M Cáceres, Kimberly M Thompson.   

Abstract

Policy makers face a number of difficult choices as they develop policies to ensure maintenance of a polio-free world following global eradication and certification. These policy decisions include choices about immunization, outbreak response (including whether to create a vaccine stockpile), surveillance, containment, management of chronic excretors, and investment in future research. This paper focuses on identifying the categories of decisions and characterizing the actual factors that country-level policy makers must weigh to manage polio risks during the first 5 years after certification. Building on a comprehensive literature review, we report the results of the first qualitative analysis to: (1) systematically characterize each type of decision and the relevant options during the first 5 years after certification, (2) clearly identify critical factors that influence the choices, and (3) specifically demonstrate the interdependence among the decisions to produce a reduced set of decision options. This paper explicitly focuses on the different perspectives of developed and developing countries in characterizing the options. While the management of polio risk in the postcertification period presents important challenges, this comprehensive approach helps simplify the process by focusing on critical decisions.

Mesh:

Substances:

Year:  2003        PMID: 14745382

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


  7 in total

1.  Firearm injuries: epidemic then, endemic now.

Authors:  Katherine Kaufer Christoffel
Journal:  Am J Public Health       Date:  2007-02-28       Impact factor: 9.308

2.  Eradicating polio: the dollars and sense.

Authors:  Kimberly M Thompson
Journal:  MedGenMed       Date:  2007-10-15

3.  The case for cooperation in managing and maintaining the end of poliomyelitis: stockpile needs and coordinated OPV cessation.

Authors:  Kimberly M Thompson; Radboud J Duintjer Tebbens
Journal:  Medscape J Med       Date:  2008-08-13

4.  The risks, costs, and benefits of possible future global policies for managing polioviruses.

Authors:  Kimberly M Thompson; Radboud J Duintjer Tebbens; Mark A Pallansch; Olen M Kew; Roland W Sutter; R Bruce Aylward; Margaret Watkins; Howard E Gary; James Alexander; Hamid Jafari; Stephen L Cochi
Journal:  Am J Public Health       Date:  2008-05-29       Impact factor: 9.308

5.  Preeradication vaccine policy options for poliovirus infection and disease control.

Authors:  Kimberly M Thompson; Mark A Pallansch; Radboud J Duintjer Tebbens; Steve G Wassilak; Jong-Hoon Kim; Stephen L Cochi
Journal:  Risk Anal       Date:  2013-03-05       Impact factor: 4.000

Review 6.  Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs.

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Konstantin M Chumakov; Neal A Halsey; Tapani Hovi; Philip D Minor; John F Modlin; Peter A Patriarca; Roland W Sutter; Peter F Wright; Steven G F Wassilak; Stephen L Cochi; Jong-Hoon Kim; Kimberly M Thompson
Journal:  Risk Anal       Date:  2013-03-28       Impact factor: 4.000

7.  Potential Future Use, Costs, and Value of Poliovirus Vaccines.

Authors:  Kimberly M Thompson; Dominika A Kalkowska
Journal:  Risk Anal       Date:  2020-07-09       Impact factor: 4.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.